Eli Lilly's diabetes drug Mounjaro gets approval for a new use USA TodayUS FDA approves Lilly's Mounjaro to reduce cardiovascular risk ReutersFDA approves new use of popular diabetes drug WNDUMounjaro Is Now Approved to Lower the Risk of Heart Events Time MagazineLilly scores Novo-pressuring Mounjaro expansion to curb heart risks in diabetes patients Fierce PharmaLilly Diabetes Shot Mounjaro Wins US Approval for Heart Disease Bloomberg.comFDA approves Lilly's Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetes PR NewswireMounjaro scores FDA approval to reduce CV risk; Teva to buy an approved drug Endpoints NewsFDA approves Lilly’s Mounjaro to reduce cardiovascular risk Indianapolis Business Journal
Weight-loss drugs could help treat other health conditions. Here’s what could be next The Independent
The right way to stop taking Ozempic, Wegovy, or Mounjaro, according to doctors Yahoo Creators
Eli Lilly gets green light to market Mounjaro for heart attacks and strokes in the US medwatch.com
Lilly joins Novo in cardiovascular space after FDA nod for GLP-1/GIP agonist Mounjaro BioSpace
FDA approves new use of popular diabetes drug WTAP
FDA Expands Tirzepatide Label to Reduce Cardiovascular Risk in Type 2 Diabetes The American Journal of Managed Care
Doctors not 'fixated' on weight-loss drug Mounjaro, says coroner BBC
GLP-1 Diabetes Drug Mounjaro Gets FDA Okay to Reduce Heart Attack and Stroke Everyday Health
Mounjaro Approved to Reduce MACE Risk in Adults With T2DM Medical Professionals Reference
FDA Approves Mounjaro to Lower Cardiovascular Risk in Type 2 Diabetes Based on SURPASS-CVOT BioPharm International
Mounjaro Gets FDA Approval to Reduce Cardiovascular Risk in People With Type 2 Diabetes Verywell Health
Why Is Eli Lilly (LLY) Getting A Bigger Role For Mounjaro? Yahoo Finance
FDA approves new use of popular diabetes drug WCAX
The BioPharm Brief: Mounjaro, ADCs, and Biosimilars BioPharm International
FDA Approves Mounjaro for Cardiovascular Risk Reduction 조선일보
FDA approves new use of popular diabetes drug WAFB
Mounjaro Can Now Be Prescribed to Lower Heart Attack and Stroke Risk in Adults with Type 2 Diabetes Medical Daily
FDA approves new use of popular diabetes drug WTOC
Mounjaro Approved for Heart Attack, Stroke Risk Reduction in Diabetes 조선일보
FDA approves new use of popular diabetes drug WILX
FDA approves new use of popular diabetes drug WTVG
FDA approves new use of popular diabetes drug WLFI
FDA Approves Lisraya for Adults with Dermatomyositis, Bixlenvo for Virologically Suppressed Adults with HIV, Mounjaro to Reduce MACE in Adults with Type 2 Diabetes Pharmaceutical Executive
FDA approves new use of popular diabetes drug FOX19 | Cincinnati
Eli Lilly's diabetes drug wins FDA approval to lower heart attack and stroke risk qz.com
ACACIA-HCM’s Full Results, Mounjaro for MACE, and ESC News Cardiac Wire
FDA approves new use of popular diabetes drug WABI
Eli Lilly (LLY) Wins FDA Approval For Mounjaro Heart Risk Reduction simplywall.st
FDA approves tirzepatide for reducing cardiovascular risk in adults with type 2 diabetes Cardiovascular Business
Mounjaro Vs Trulicity: Eli Lilly’s New FDA Win Puts Its Blockbuster Weight-Loss Drug In Focus Stocktwits
FDA approves new use of popular diabetes drug WGEM
FDA approves new use of popular diabetes drug KPTV
FDA approves new use of popular diabetes drug WHSV
FDA approves new use of popular diabetes drug WITN
FDA approves new use of popular diabetes drug KY3
FDA approves new use of popular diabetes drug KCTV
Lilly’s Mounjaro wins US label expansion for cardiovascular risk reduction Yahoo
FDA approves new use of popular diabetes drug KSNB
Zepbound Vs. Mounjaro: What’s The Difference? Forbes